Funded Tech Companies
CanSense
Wondering who provided funding to CanSense? Nonacus, Development Bank of Wales and Mercia Fund Management joined the equity holders in this healthcare services company.
Company Overview
Company Name
CanSense
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
Broomfield And Alexander Charter Court Swansea Enterprise Pa
Swansea, Wales, SA7 9FS
UK
Swansea, Wales, SA7 9FS
UK
Phone
Undisclosed
Website
Email Address
Company Background Information
Overview
CanSense: delivering a blood test solution for the early diagnosis of bowel cancer. Bowel cancer (also known as colorectal cancer) is the third most common cancer and the fourth most common cause of deaths globally. It accounts for roughly 1.4 million new cases and 700,000 deaths annually. In Europe bowel cancer is the second most common cancer, with 450,000 new cases per year. Incidence is particularly high and is continuing to rise in developed countries. It is well established that early detection is key to saving lives.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
3/8/2023
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chief Executive Officer
Adam Bryant
Founder
Peter Dunstan
Founder
Dean Harris
Founder
Cerys Jenkins
Company Investors
Browse more funded tech companies:
Cansativa Group | Cantai Therapeutics
Share this article
About Our VC Transaction Database
This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs